The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study (Q38404870)

2 September 2017

The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study (English)

1 reference

2 September 2017

Orlaith B Kelly

1

1 reference

2 September 2017

Catherine Dillane

2

1 reference

2 September 2017

Stephen E Patchett

3

1 reference

2 September 2017

Gavin C Harewood

4

1 reference

2 September 2017

Frank E Murray

5

1 reference

2 September 2017

4 April 2015

1 reference

Digestive Diseases and Sciences

2 September 2017

1 reference

2 September 2017

60

1 reference

2 September 2017

8

1 reference

2 September 2017

2280-2286

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-015-3642-8

2 September 2017

0 references

cites work

Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3642-8

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3642-8

The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3642-8

Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3642-8

Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3642-8

Inappropriate use of proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3642-8

Proton pump inhibitors: a survey of prescribing in an Irish general hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3642-8

Overprescribing proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3642-8

Model-based cost-effectiveness analysis of interventions aimed at preventing medication error at hospital admission (medicines reconciliation).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3642-8

A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3642-8

Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3642-8

Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme.

21 January 2018

1 reference

12 December 2020

The prevalence of and the clinical and demographic characteristics associated with high-intensity proton pump inhibitor use

1 reference

12 December 2020

Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients

1 reference

12 December 2020

Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization

1 reference

12 December 2020

10.1007/S10620-015-3642-8

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference